OVERVIEW ON MANAGEMENT OF HEPATIC ENCEPHALOPATHY

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2019, Vol 6, Issue 5

Abstract

Minimal hepatic encephalopathy (MHE) is a neurocognitive dysfunction that is present in the majority of patients with cirrhosis. MHE has a characteristic cognitive profile that cannot be diagnosed clinically. This cognitive dysfunction is independent of sleep dysfunction or problems with overall intelligence. MHE has a significant impact on quality of life, the ability to function in daily life and progression to overt hepatic encephalopathy. Driving ability can be impaired in MHE and this may be a significant factor behind motor vehicle accidents. A crucial aspect of the clinical care of MHE patients is their driving history, which is often ignored during routine care and can add a vital dimension to the overall disease assessment. Driving history should be an integral part of the care of patients with MHE. The preserved communication skills and lack of specific signs and insight make MHE difficult to diagnose. The predominant strategies for MHE diagnosis are psychometric or neurophysiological testing. These are usually limited by financial, normative or time constraints. Studies into inhibitory control, cognitive drug research and critical flicker frequency tests are encouraging. These tests do not require a psychologist for administration and interpretation. Lactulose and probiotics have been studied for their potential use as therapies for MHE, but these are not standard-of-care practices at this time. Therapy can improve the quality of life in MHE patients but the natural history, specific diagnostic strategies and treatment options are still being investigated.

Authors and Affiliations

Dr. Mona Saber

Keywords

Related Articles

GRAPH THEORY APPLICATIONS IN BIOLOGY

Mathematics plays a key role in many disciplines of science, primarily as a mathematical modeling tool. A survey of the use of graph theoretical techniques in Biology is presented. In particular, recent work on identifyi...

SALMONELLA TYPHIMURIUM INFECTIONS TREATMENT IN MICE USING MORINGA OLIFERA AQUEOUS LEAVES EXTRACT

Inhibitory activities of Moringa olifera leaves extract was investigated using mice. Mice were divided into 3 groups of 5 mice (n=15). Group A was neither infected nor treated with the extract and was used as control. Gr...

CHALLENGES TO CONTROL TUBERCULOSIS

Tuberculosis (TB) is an infectious bacterial disease characterized by the growth of nodules or tubercules in the tissues, especially the lungs. It is caused by Mycobacterium tuberculosis. If not treated properly TB disea...

PREVALENCE OF EXCESS WEIGHT IN STUDENTS FROM NORTHEASTERN BRAZIL

Objective: To assess the prevalence of the excess weight in adolescents from São Luís, Maranhão, Northeastern Brazil. Subjects/Methods: Cross-sectional study with a sample of 513 students aged 10-19 years from public sch...

EFFECTS OF WATER HYACINTH LEAF PROTEIN CONCENTRATE ON GROWTH AND HAEMATOLOGICAL PROPERTIES OF RATS

In this study, edible form of water hyacinth leaf protein concentrate (WHLPC) was extracted. The WHLPC was used to formulate feed using different concentrations (7.73, 15.46, 23.19, and 30.92) %w/w. A control feed was fo...

Download PDF file
  • EP ID EP670693
  • DOI -
  • Views 143
  • Downloads 0

How To Cite

Dr. Mona Saber (2019). OVERVIEW ON MANAGEMENT OF HEPATIC ENCEPHALOPATHY. European Journal of Biomedical and Pharmaceutical Sciences, 6(5), 8-10. https://europub.co.uk/articles/-A-670693